Trial closure: MA38
Published:Category: Trials
Permanent trial closure of the MA38 trial: Randomized Phase II Study Comparing Two Different Schedules of Palbociclib plus Second Line Endocrine Therapy in Women with Estrogen Receptor Positive, HER2 Negative Advanced/Metastatic Breast Cancer.
Read MoreWelcome to Patient Representative Jasmine Heuring
Published:Category: Group updates
A very warm welcome to Jasmine Heuring who has joined the CCTG Patient Representatives Committee and will be supporting the Adolescents & Young Adults and Sarcoma Disease Site Committees. Jasmine is from Winnipeg Manitoba and is a cancer advocate and healthcare analyst.
Read MoreCCTG NE2 trial at the Australasian Gastro-Intestinal Trials Group Annual Scientific Meeting
Published:Category: News
The upcoming CCTG NE2 (STOPNET) trial was presented at the 25th Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting that was held in Aotearoa New Zealand from November 13 – 16.
Read MoreGastric cancer survivor now on front lines in battle against disease
Published:Category: News
From an article by Kevin Connor - Published Nov 12, 2023 • Toronto Sun
It is a full circle for Katy Kosyachkova.
Read MorePublications: MA20 PA6 substudies
Published:Category: Publications
PA6: Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial. MA20: Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Read More
Permanent Trial Closure: CE5
Published:Category: Trials
Please be aware of the permanent trial closure of the EORTC-led CE5 trial: Primary Chemotherapy with Temozolomide vs. Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study.
Read MoreCCTG Patient Representative David McMullen honoured with 2023 CCRA award
Published:Category: News
The Canadian Cancer Research Alliance (CCRA) announced the recipients of its biennial awards, recognizing significant contributions to cancer research in Canada.
Read MoreImproving survival for people with pancreatic cancer
Published:Category: News
Stories of research impact, CCS Research Impact Report. An international clinical trial has changed the way doctors treat pancreatic cancer around the world. Read More